Kanabo Group PLC - London-based medicinal cannabis - Signs distribution framework agreement with Astral Health Ltd, part of LYPHE Group. Kanabo, which listed on the London Main Market last week, says LYPHE is one of the main players in the medicinal cannabis market in the UK. Kanabo's VapePod medicinal cannabis formula will be made available to patients taking part in Project Twenty21. This will provide patients with affordable medical cannabis treatment, monitored by advisory body Drug Science.
Current stock price: 28.45 pence, up 12%
Year-to-date change: up 54% since listing on February 16
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.